חובות לטווח קצר של החברה: NeuroPace Corp (NPCE)

NeuroPace, Inc. (NPCE) focuses on suppressing epileptic seizures via the intelligent RNS system, generating profit from implantation and monitoring. In-house neuroengineers provide the technological edge, while the commercial division is bolstered by experienced sales representatives. This chart of the share price on the GURU.Markets platform for this medical equipment manufacturer is fixed at 0.00.

In-house neurostimulator assembly lines in the US provide NeuroPace, Inc. (NPCE) with high technological autonomy. This current liabilities metric aggregates the total sum of all debts with a maturity of up to one year. The trend on the chart reflects the balance between liquidity and the speed of debt servicing. The reduction in leverage confirms the stability of operating capital, which enhances the asset's investment attractiveness during periods of market volatility.